Abstract
Abnormal or excessive bleeding during neurosurgical procedures could have devastating consequences and requires diligent, expedient workup and management coordinated by the neurosurgeon and anesthesiologist working together. Multiple modalities now exist in order to evaluate the patient’s ability to clot blood, and point of care testing can isolate the problem to platelet dysfunction, coagulation cascade abnormalities, or some other global phenomenon. Hemostatic agents and alterations in hemodynamics may help to reduce this blood loss and allow the surgeon to identify and control the source of bleeding. Blood salvage techniques may be utilized to reduce the amount of allogenic blood products received, and specific diagnostic techniques may also help facilitate hemostasis and direct the administration of medication to help improve platelet function and reduce or inhibit thrombolysis. A systematic and coordinated effort can decrease overall blood loss and minimize associated morbidity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Braun H, Shields P. Local anesthesia: its scientific basis and practical use. Philadelphia: Lea & Febinger; 1914.
Cushing H. Technical methods of performing certain cranial operations. Surg Gynecol Obstet. 1908;6:227–46.
Frazier CH. Remarks upon the surgical aspects of operable tumors of the cerebrum. In: Mills CK, editor. Tumors of the cerebrum, their focal diagnosis, and surgical treatment. Philadelphia: Pennock; 1906.
Walker AE. A history of neurological surgery. New York: Hafner; 1967.
Horsley V. Antiseptic wax. Br Med J. 1892;1:1165.
Cushing H, Bovie WT. Electro-surgery as an aid to the removal of intracranial tumors. Surg Gynecol Obstet. 1928;47:752–84.
Stangerup SE, Thomsen HK. Histological changes in the nasal mucosa after hot-water irrigation. An animal experimental study. Rhinology. 1996;34:14–7.
Council on Pharmacy and Chemistry. Absorbable Gelatin sponge—new and nonofficial remedies. JAMA. 1947;135:921.
Gerald AG. Update on hemostasis: neurosurgery. Surgery. 2007;142:S55–60.
Herndon JH, Grillo HC, Risenborough EJ, et al. Compression of the brain and spinal cord following use of gelfoam. Arch Surg. 1972;104:107.
Friedman J, Whitecloud 3rd TS. Lumbar cauda equina syndrome associated with the use of gelfoam: case report. Spine. 2001;26:E485–7.
Abbot WM, Austen WG. The effectiveness and mechanism of collagen-induced topical hemostasis. Surgery. 1975;78:723–9.
Levy ML, Amar AP. The use of oxidized regenerated cellulose in neurosurgical procedures. Surg Technol Int. 1998;7:467–71.
Tschan CA, Nie M, Schwandt E, et al. Safety and efficacy of microporous polysaccharide hemospheres in neurosurgery. Neurosurgery. 2011;69(1 (Suppl Operative)):49–63.
Arand AG, Sawaya R. Intraoperative chemical hemostasis in neurosurgery. Neurosurgery. 1986;18:223–33.
Lew W, Weaver F. Clinical use of topical thrombin as a surgical hemostat. Biologics. 2008;2(4):593–9.
Streiff MB, Ness PM. Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure. Transfusion. 2002;42:18–26.
Martinowitz U, Saltz R. Fibrin sealant. Curr Opin Hematol. 1996;3(5):395–402.
Shaffrey CI, Spotnitz WD, Shaffrey ME, et al. Neurosurgical applications of fibrin glue: augmentation of dural closure in 134 patients. Neurosurgery. 1990;26(2):207–10.
Oz MC, Rondinone JF, Shargill NS. FloSeal Matrix: new generation topical hemostatic sealant. J Card Surg. 2003;18:486–93.
Sollevi A. Hypotensive anesthesia and blood loss. Acta Anaesthesiol Scand Suppl. 1988;89:39–43.
Fahmy NM. Indications and contraindications for deliberate hypotension with a review of its cardiovascular effects. Int Anesthesiol Clin. 1979;17(1):175–87.
Shapiro HM. Physiology and pharmacologic regulation of cerebral blood flow. In: ASA refresher course in anesthesiology. Philadelphia, Pa: J.B. Lippincott; 1977. p. 161–78.
Pasch T, Huk W. Cerebral complications following induced hypotension. Eur J Anaesthesiol. 1986;3(4):299–312.
Hickey RF, Verrier ED, Baer RW, et al. A canine model of acute coronary artery stenosis: effects of deliberate hypotension. Anesthesiology. 1983;59(3):226–36.
Hartman JC, Kampine JP, Schmeling WT, et al. Steal-prone coronary circulation in chronically instrumented dogs: isoflurane versus adenosine. Anesthesiology. 1991;74(4):744–56.
Knight PR, Lane GA, Hensinger RN, et al. Catecholamine and renin-angiotensin response during hypotensive anesthesia induced by sodium nitroprusside or trimethaphan camsylate. Anesthesiology. 1983;59(3):248–53.
Fukayama H, Ito H, Shimada M, et al. Effects of hypotensive anesthesia on endocrine systems in oral surgery. Anesth Prog. 1989;36(4-5):175–7.
Dilger JA, Tetzlaff JE, Bell GR, et al. Ischaemic optic neuropathy after spinal fusion. Can J Anaesth. 1998;45(1):63–6.
Scott BH, Seifert FC, Glass PS, et al. Blood use in patients undergoing coronary artery bypass surgery: impact of cardiopulmonary bypass pump, hematocrit, gender, age and body weight. Anesth Analg. 2003;97:958–63.
Pierce LR, Gaines A, Varricchio F, et al. Hemolysis and renal failure associated with use of sterile water for injection to dilute 25% human albumin solution. Am J Health Syst Pharm. 1998;55:1057–70.
Boudreaux JP, Bornside GH, Cohn Jr I. Emergency autotransfusion: partial cleansing of bacteria-laden blood by cell washing. J Trauma. 1983;23:31–5.
Waters JH, Tuohy MJ, Hobson DF, et al. Bacterial reduction by cell salvage washing and leukocyte depletion filtration. Anesthesiology. 2003;99:652–5.
Bland LA, Villarino ME, Arduino MJ, et al. Bacteriologic and endotoxin analysis of salvaged blood used in autologous transfusions during cardiac operations. J Thorac Cardiovasc Surg. 1992;103:582–8.
Kang Y, Aggarwal S, Pasculle AW, et al. Bacteriologic study of autotransfusion during liver transplantation. Transplant Proc. 1989;21:35–8.
Smith RN, Yaw PB, Glover JL. Autotransfusion of contaminated Intraperitoneal blood: an experimental study. J Trauma. 1978;18:341–4.
Vamvakas EC. Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation. Transfusion. 1995;35:760–8.
Fisher ER, Turnbull Jr RB. Cytologic demonstration and significance of tumor cells in the mesenteric venous blood in patients with colorectal carcinoma. Surg Gynecol Obstet. 1955;100:102–5.
Edelman MJ, Potter P, Mahaffey KG, et al. The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the RC-400 leukocyte depletion filter. Urology. 1996;47:179–81.
Perseghin P, Vigano M, Rocco G, et al. Effectiveness of leukocyte filters in reducing tumor cell contamination after intraoperative blood salvage in lung cancer patients. Vox Sang. 1997;72:221–4.
Smith DF, Mihm FG, Mefford I. Hypertension after intraoperative autotransfusion in bilateral adrenalectomy for pheochromocytoma. Anesthesiology. 1983;58:182–4.
Cash JD, Gader AMA, De Costa J. The release of plasminogen activator and factor VIII by LVP, AVP, DDAVP, AT III, and OT in man. Br J Haematol. 1984;30:363–4.
Cooney KA, Ginsburg D, Ruggeri ZM. von Willebrand disease. In: Loscalzo J, Schafer AL, editors. Thrombosis and hemorrhage. Boston, MA: Blackwell Scientific Publications; 1994. p. 657–82.
Mannucci PM, Remuzzi G, Pusineri F. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med. 1983;308:8–12.
Janssens M, Joris J, David JL, et al. High-dose aprotinin reduces blood loss in patients undergoing total hip replacement surgery. Anesthesiology. 1994;80:23–9.
Levi MM, Vink R, de Jonge E. Management of bleeding disorders by prohemostatic therapy. Int J Hematol. 2002;72 suppl 2:139–44.
Murkin JM, Lux J, Shannon NA, et al. Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. J Thorac Cardiovasc Surg. 1994;107:554–61.
Tanaka K, Takao M, Yada I. Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery. J Cardiothorac Anesth. 1989;3:181–8.
Davis R, Whittington R. Aprotinin: a review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery. Drugs. 1995;49:954–83.
Rinder CS, Mathew JP, Ringer HM, et al. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology. 1991;75:563–70.
Levy JH, Schwieger IM, Zaidan JR, et al. Evaluation of patients at risk for protamine reactions. J Thorac Cardiovasc Surg. 1989;98:200–4.
Stratmann G, Russell IA, Merrick SH. Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair. Ann Thorac Surg. 2003;76(6):2094–7.
Weiss EJ, Bray PF, Tayback M, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med. 1996;334:1090–4.
Jobes DR, Schwartz AJ, Ellison N, et al. Monitoring heparin anti-coagulation and its neutralization. Ann Thorac Surg. 1981;31(2):161–6.
Gravlee GP, Rogers AT, Dudas LM, et al. Heparin management protocol for cardiopulmonary bypass influences postoperative heparin rebound but not bleeding. Anesthesiology. 1992;76(3):393–401.
Mongan PD, Hosking MP. The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelestographic risk stratification. Anesthesiology. 1992;77(1):38–46.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Wemhoff, M.P., Jellish, W.S. (2016). Evaluation and Management of Untoward Intraoperative Bleeding. In: Loftus, C. (eds) Anticoagulation and Hemostasis in Neurosurgery. Springer, Cham. https://doi.org/10.1007/978-3-319-27327-3_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-27327-3_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-27325-9
Online ISBN: 978-3-319-27327-3
eBook Packages: MedicineMedicine (R0)